Chemours Co CC
5 targets with a reported result
Releases of the last 3 yearsThe numbers CC said it expected, in its earnings releases, next to what it then reported for the same period.
Target by target
Each target, with the sentence it came from · release and 10-Q or 10-K
| Target | What the company said | Reported | Result | |
|---|---|---|---|---|
| EBITDA (company-defined) Fiscal 2026 |
Given $800.00M to $900.00M release Feb 19, 2026
Kept $800.00M to $900.00M release May 5, 2026
Lowered $775.00M to $825.00M release Aug 4, 2026
Lowered $775.00M to $800.00M release Nov 2, 2026
|
– | No standard number | |
The company's wordsThe Company expects to deliver 2026 Net Sales growth in the range of 3 to 5% and Adjusted EBITDA of $800 million to $900 million, primarily driven by increased TSS and APM Performance Solutions demand, expected pricing strength in TT, and further benefited by continued cost improvement realization in TT and APM throughout the year. release Feb 19, 2026 Full Year 2026 Outlook The Company continues to expect 2026 Net Sales to grow in the range of 3% to 5% over 2025, with Adjusted EBITDA between $800 million and $900 million. release May 5, 2026 Full Year 2026 Outlook The Company continues to expect 2026 Net Sales to grow in the range of 1% to 5% over 2025, with Adjusted EBITDA between $775 million and $825 million. release Aug 4, 2026 Full Year 2026 Outlook The Company expects 2026 Net Sales to grow approximately 2% over 2025, with Adjusted EBITDA between $775 million and $800 million. release Nov 2, 2026 | ||||
| EBITDA (company-defined) Q4 of fiscal 2026 |
Given $160.00M to $185.00M release Nov 2, 2026
|
– | No standard number | |
The company's wordsEXHIBIT 99.1 Fourth Quarter 2026 Outlook In the fourth quarter, the Company expects consolidated Net Sales to decrease in the range of 5% to 10%, sequentially, driven by seasonality in TSS and TT, with consolidated Adjusted EBITDA expected to range between $160 million and $185 million. release Nov 2, 2026 | ||||
| EBITDA (company-defined) Q3 of fiscal 2026 |
Given $175.00M to $205.00M release Aug 4, 2026
|
– | No standard number | |
The company's wordsEXHIBIT 99.1 Third Quarter 2026 Outlook In the third quarter, the Company expects consolidated Net Sales to decrease in the range of 5% to flat, sequentially, driven by weaker Opteon™ blends aftermarket refrigerant demand in TSS, with consolidated Adjusted EBITDA expected to range between $175 million and $205 million. release Aug 4, 2026 | ||||
| EBITDA (company-defined) Q2 of fiscal 2026 |
Given $220.00M to $250.00M release May 5, 2026
|
– | No standard number | |
The company's wordsEXHIBIT 99.1 Second Quarter 2026 Outlook In the second quarter, the Company anticipates consolidated Net Sales to increase in the range of 15% to 20% sequentially, driven by favorable seasonal trends, with consolidated Adjusted EBITDA expected to range between $220 million and $250 million. release May 5, 2026 | ||||
| EBITDA (company-defined) Q1 of fiscal 2026 |
Given $120.00M to $150.00M release Feb 19, 2026
|
– | No standard number | |
The company's wordsFirst Quarter 2026 Outlook In the first quarter, the Company anticipates consolidated Net Sales to increase in the range of 3 to 5% sequentially driven by TSS, with consolidated Adjusted EBITDA expected to range between $120 million and $150 million. release Feb 19, 2026 | ||||
| EBITDA (company-defined) Fiscal 2025 (ended Dec 31, 2025) |
Given $825.00M to $975.00M release Feb 18, 2025
Lowered $825.00M to $950.00M release May 6, 2025
Lowered $775.00M to $825.00M release Aug 5, 2025
|
– | No standard number | |
The company's wordsThe Company expects to deliver 2025 Adjusted EBITDA of $825 million to $975 million. release Feb 18, 2025 The Company expects to deliver Adjusted EBITDA of $825 million to $950 million in 2025. release May 6, 2025 Full Year 2025 Outlook … The Company expects to deliver Net Sales of $5.9 billion to $6.0 billion and Adjusted EBITDA of $775 million to $825 million in 2025, with referenced Q3 operational disruptions in TT and outage impacts in APM totaling $35M, collectively, to be resolved in the fourth quarter. release Aug 5, 2025 | ||||
| Capital expenditures Fiscal 2025 (ended Dec 31, 2025) |
Given $225.00M to $275.00M release May 6, 2025
Narrowed $250.00M release Aug 5, 2025
|
$213.00M 10-K filed 2026-02-24 |
Below the range | |
The company's wordsFull Year 2025 Outlook … Anticipated capital expenditures are expected to range between $225 million to $275 million, and while anticipating free cash flow to be slightly positive in the second quarter, the Company projects free cash flows conversion to be in the range of 60-80% in the second half. release May 6, 2025 Anticipated capital expenditures are expected to be approximately $250 million, with Free Cash Flow Conversion to be between 60-80% in the second half of 2025 through a seasonal net working capital unwind. release Aug 5, 2025 | ||||
| Revenue Fiscal 2025 (ended Dec 31, 2025) |
Given $5.90B to $6.00B release Aug 5, 2025
|
$5.81B 10-K filed 2026-02-24 |
Below the range | |
The company's wordsFull Year 2025 Outlook … The Company expects to deliver Net Sales of $5.9 billion to $6.0 billion and Adjusted EBITDA of $775 million to $825 million in 2025, with referenced Q3 operational disruptions in TT and outage impacts in APM totaling $35M, collectively, to be resolved in the fourth quarter. release Aug 5, 2025 | ||||
| EBITDA (company-defined) Q4 of fiscal 2025 |
Given $130.00M to $160.00M release Nov 6, 2025
|
– | No standard number | |
The company's wordsFourth Quarter 2025 Outlook … In the fourth quarter, the Company anticipates consolidated Net Sales to decrease 10-15% sequentially given seasonal impacts, with consolidated Adjusted EBITDA expected to range between $130 million and $160 million. release Nov 6, 2025 | ||||
| Capital expenditures Q4 of fiscal 2025 |
Given $50.00M release Nov 6, 2025
|
$45.00M 10-K filed 2026-02-24 |
Below the range | |
The company's wordsFourth Quarter 2025 Outlook … The Company also anticipates capital expenditures to be in the range of $50 million, with Free Cash Flow Conversion to be between 50%-70%. release Nov 6, 2025 | ||||
| EBITDA (company-defined) Q3 of fiscal 2025 |
Given $175.00M to $195.00M release Aug 5, 2025
|
– | No standard number | |
The company's wordsEXHIBIT 99.1 Third Quarter 2025 Outlook In the third quarter, the Company anticipates consolidated Net Sales to decrease 4-6% sequentially, with consolidated Adjusted EBITDA expected to range between $175 million and $195 million. release Aug 5, 2025 | ||||
| Capital expenditures Q1 of fiscal 2025 |
Given $80.00M release Feb 18, 2025
|
$84.00M 10-Q filed 2025-05-06 |
Above the range | |
The company's wordsOperating cash flow in the first quarter is expected to reflect a net usage, consistent with traditional seasonality, paired with capital expenditures in the range of $80 million. release Feb 18, 2025 | ||||
| EBITDA (company-defined) Q3 of fiscal 2024 |
Given $15.00M to $20.00M release Aug 1, 2024
|
– | No standard number | |
The company's wordsAdditionally, the Company anticipates a high-single digit sequential decline in Adjusted EBITDA for the third quarter, reflecting approximately $15 to $20 million of costs related to the unplanned shutdown at Altamira. release Aug 1, 2024 | ||||
| Capital expenditures Q2 of fiscal 2024 |
Given $80.00M release Apr 30, 2024
|
$73.00M 10-Q filed 2024-08-01 |
Below the range | |
The company's wordsSecond quarter capital expenditures are expected to be approximately $80 million. release Apr 30, 2024 | ||||
2 targets far from the company's reported total, so not compared (usually a target for one product, segment or definition)
- Operating cash flow, Q2 of fiscal 2024: said $500.00M, reported -$620.00M. The company's words
- Operating cash flow, Q1 of fiscal 2024: said $400.00M, reported -$290.00M. The company's words
Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (13 releases since 2024-02-29), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.
Sources
The outlook sentences of each earnings release (8-K item 2.02, exhibit 99), read without AI; results from SEC's XBRL company facts, as first reported.
Also
Earnings releases: each release in full.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/CC/export.csv") into a cell.